Microscopic satellitosis in patients with primary cutaneous melanoma: Implications for nodal basin staging Journal Article


Authors: Kimsey, T. F.; Cohen, T.; Patel, A.; Busam, K. J.; Brady, M. S.
Article Title: Microscopic satellitosis in patients with primary cutaneous melanoma: Implications for nodal basin staging
Abstract: Background: Microscopic satellitosis in melanoma is uncommon. The role of regional basin staging/therapy in patients with this high-risk feature has not been well defined. Methods: Patients presenting from 1996 to 2005 with clinically localized melanoma containing microscopic satellitosis were identified from a prospective, single-institution database. Multiple factors were analyzed to determine their predictive value for recurrence. The management of the draining nodal basin was evaluated to determine its impact on recurrence and survival. Results: Thirty-eight patients presented to our institution during this time period with clinically localized melanoma containing microscopic satellitosis. The 5-year overall and disease-free survivals in these patients were 34% and 18%, respectively. Sixty-eight percent had pathologically involved regional nodal metastases. With median follow-up of 21 months, 68% recurred, with a median time to recurrence of 9 months. Lymphovascular invasion (LVI) (p = 0.01), tumor regression (p = 0.04), and positive regional lymph nodes (p = 0.02) were associated with an increased risk of recurrence. Of the 31 patients who underwent sentinel lymph node (SLN) biopsy, 22 had metastasis in the SLN (71%). Fifteen of these patients underwent completion lymphadenectomy (CLND) and seven were observed. There was no difference in disease-free survival (DFS), disease-specific survival (DSS), or overall survival (OS) between these groups (p = 0.42). Conclusions: Pathological lymph node metastases were more prevalent (68%) than in any group previously defined. Regional nodal status predicted recurrence but not nodal recurrence. In SLN-positive patients, CLND did not improve DFS, DSS, or OS, although the number of patients was small. Further studies are needed to determine the utility of regional nodal staging/therapy in these high-risk patients. © 2009 Society of Surgical Oncology.
Keywords: cancer survival; clinical article; overall survival; cancer recurrence; cancer risk; cancer patient; disease free survival; cancer staging; follow up; lymph node metastasis; lymph nodes; lymphatic metastasis; neoplasm staging; sentinel lymph node biopsy; lymphadenectomy; melanoma; skin neoplasms; neuropathy; tumor regression; cancer invasion; survival time; predictive validity; satellitosis
Journal Title: Annals of Surgical Oncology
Volume: 16
Issue: 5
ISSN: 1068-9265
Publisher: Springer  
Date Published: 2009-05-01
Start Page: 1176
End Page: 1183
Language: English
DOI: 10.1245/s10434-009-0350-7
PUBMED: 19224283
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 2" - "Export Date: 30 November 2010" - "CODEN: ASONF" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Tzeela Cohen
    10 Cohen
  2. Troy F Kimsey
    2 Kimsey
  3. Mary Sue Brady
    203 Brady
  4. Klaus J Busam
    688 Busam
  5. Ami Patel
    3 Patel